Autoimmune hepatitis and complexities in management

6Citations
Citations of this article
25Readers
Mendeley users who have this article in their library.

Abstract

Autoimmune hepatitis (AIH) is a rare heterogenous immune-mediated liver disease that for the majority has effective therapy, usually resulting in excellent prognosis. Treatment is based on immunosuppression using standard therapy with corticosteroids and azathioprine. Second-line therapeutic options exist for those who are non-responders ('difficult to treat AIH') or intolerant to standard therapy; however, their use is not standardised, and in addition, there is vast variation in practice and efficacy. Given the rarity of AIH, expertise in its management can be limited to large referral programmes. In this case-based review, we aim to discuss common clinical dilemmas encountered by clinicians managing adult patients with AIH and address the related competencies in the 2010 Gastroenterology curriculum.

Cite

CITATION STYLE

APA

Janmohamed, A., & Hirschfield, G. M. (2019). Autoimmune hepatitis and complexities in management. Frontline Gastroenterology, 10(1), 77–87. https://doi.org/10.1136/flgastro-2018-101015

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free